The Trump Administration proposed new rules for pharmacy benefits managers promises to save Americans billions of dollars thanks to lower prices for prescription drugs, according to Eli Lilly CEO David Ricks, writing in an op-ed for USA Today. The proposed rule would require rebates from pharmaceutical companies to health insurance plans […]
By Grace-Marie Turner, Galen Institute The Biden administration made “the single worst presidential economic decision since Nixon’s wage-and-price controls,” The Wall Street Journal wrote in a lead editorial last week. And we agree. U.S. Trade Representative Katherine Tai said the U.S. would agree to “waive” intellectual property rights to Covid-19 vaccines and treatments and encourage other […]
By Dr. Marion Mass Congress is considering legislation to rein in runaway drug prices. But any new law would be just political theater unless it shines a light on how pharmaceutical benefit managers (PBMs) manipulate drug pricing. We soothe ourselves with slogans about America’s free-market health care. The reality is very different. […]
